Stan Lee Estate Partners with ElevenLabs for AI Voice Likeness Trumps AntiWeaponization Fund Faces Pushback from MAGA Base Poll Suggests Spain Blocks Polymarket and Kalshi Amid Gambling License Investigation Fed Dissenters Object to Rate Cut Signal Citing Uncertainty Over Next Move Indias Gen Z Cockroach Movement Gains Momentum as Website Goes Offline Traders Signal Potential US Government Stakes in IonQ Micron and Anduril ENIC Q4 2025 Earnings Earnings Beat Estimates Amid Challenging Market Conditions EGBN Q1 2026 Earnings EPS Surpasses Estimates by Over 43 FTFT Q2 2024 Earnings Loss Per Share of 009 as Stock Rises ACRS Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment LYEL Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency and Pipeline Progress Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances Nova Minerals NVA Weakness Tests Key Support After 34 Decline Gamblingcom Group GAMB Slides 2 as Shares Test Critical Support Near 230 First American Corporation FAF Holds Steady Near Support Amid Modest Decline Bolt Biotherapeutics BOLT Gains 36 as Biotech Sector Shows Renewed Interest BRX Sees Marginal Decline as Brixmor Property Group Hovers Near Support Zone SPME Q1 2026 Earnings Preferred Shares Miss EPS Estimates Stock Declines Nomad Foods Limited Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Signals AMPY Q1 2026 Earnings Significant earnings miss as reported loss of 093 per share versus consensus estimate MDRR Q2 2021 Earnings EPS Surprises to the Upside Despite Revenue Absence LGCY Q1 2026 Earnings EPS Beats Estimates by 244 Revenue Not Disclosed KELYA Q1 2026 Earnings EPS Miss of 6026 Despite Positive Stock Reaction Broadcom Deepens AI Chip Packaging Collaboration with Applied Materials CPSH Q1 2026 Earnings Significant EPS Miss Amidst Stock Surge Unclear Revenue Picture BioAge Labs BIOA Slips Slightly as Biotech Sector Holds Steady